Predictive Value of Pretransplant Cytomegalovirus-Specific Cellular Immunity for Posttransplant CMV Infection in Liver Transplant Recipients Under Antiviral Prophylaxis
Transplantation Proceedings · 2025
DOI: 10.1016/j.transproceed.2025.07.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2025. Verfasst von Elif Seren Tanriverdi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Inonu University Faculty of Medicine, Malatya, Türkiye. Electronic address: seren.tanriverdi@inonu.edu.tr. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Liver Transplantation, Antiviral Agents, Cytomegalovirus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Inonu University.
Abstract (Originalsprache)
BACKGROUND: Existing data suggest that cytomegalovirus (CMV)-specific cell-mediated immunity (CMV-CMI) in solid organ recipients may predict post-transplant CMV infection, but the available information is still limited, and needs to be validated for larger patient populations under certain circumstances. This study aimed to determine whether CMV-CMI could predict post-transplant CMV infection in liver transplant recipients (LTRs) receiving antiviral prophylaxis (AVP). METHODS: A total of 1769 LTRs at the Inonu University Liver Transplantation Institute were retrospectively analyzed. CMV-CMI in a total of 334 patients (> 91% were CMV donor [D] positive/recipient [R] positive) who received AVP were analyzed using the CMV-Interferon (CMV-QF; QuantiFERON-CMV, Qiagen, Germany) assay within the week before transplantation. Patients were divided into two groups: group 1 (positive; n = 171, 51.2%) and group 2 (negative; n = 163, 48.8%). Patient variables were analyzed statistically. RESULTS: A total of 124 LTRs developed CMV infection. Patients' pre-transplant characteristics did not differ significantly by their CMV-CMI result. A significantly lower percentage of LTRs with CMV-CMI positive developed infection than those with negatives (7.6% vs 68.1%, P < .001). All CMV-CMI positive patients fully recovered with antiviral treatment but only 76.6% of LTRs with negative CMV-CMI (P = .032). Logistic regression analysis showed that a negative CMV-CMI was associated with a 26 times increased risk of CMV infection compared to those with positive CMV-CMI (odds ratio [OR] = 25.9, P < .001). Female recipients developed CMV infection earlier after cessation of AVP than male recipients (median = 128 vs 144 days, P = .038). CONCLUSIONS: The pre-transplant status of CMV-CMI may be a strong indicator of post-transplant CMV infection for LTRs receiving AVP. Therefore, further consideration should be made for the LTRs with negative CMV-CMI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology, Inonu University Faculty of Medicine, Malatya, Türkiye. Electronic address: seren.tanriverdi@inonu.edu.tr.
- Department of Medical Microbiology, Inonu University Faculty of Medicine, Malatya, Türkiye.
- Department of Infectious Diseases and Clinical Microbiology, Guven Health Group Guven Private Hospital Ayrancı, Ankara, Türkiye.
- Department of Surgery and Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Türkiye.
- Department of Infectious Diseases and Clinical Microbiology, Inonu University Faculty of Medicine, Malatya, Türkiye.
- Department of Biostatistics and Medical Informatics, Inonu University Faculty of Medicine, Malatya, Türkiye.
Förderung
- Inonu University
Zitieren
APA
Tanriverdi, E. S., Yakupogullari, Y., Bayindir, Y., Akbulut, S., Toplu, S. A., Bag, H. G. G., Isik, B., Otlu, B., & Yilmaz, S. (2025). Predictive Value of Pretransplant Cytomegalovirus-Specific Cellular Immunity for Posttransplant CMV Infection in Liver Transplant Recipients Under Antiviral Prophylaxis. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2025.07.006
Vancouver
Tanriverdi ES, Yakupogullari Y, Bayindir Y, Akbulut S, Toplu SA, Bag HGG, et al. Predictive Value of Pretransplant Cytomegalovirus-Specific Cellular Immunity for Posttransplant CMV Infection in Liver Transplant Recipients Under Antiviral Prophylaxis. Transplantation Proceedings. 2025. doi:10.1016/j.transproceed.2025.07.006
BibTeX
@article{Tanriverdi2025,
author = {Tanriverdi, Elif Seren and Yakupogullari, Yusuf and Bayindir, Yasar and Akbulut, Sami and Toplu, Sibel Altunisik and Bag, Harika Gozde Gozukara and Isik, Burak and Otlu, Baris and Yilmaz, Sezai},
title = {Predictive Value of Pretransplant Cytomegalovirus-Specific Cellular Immunity for Posttransplant CMV Infection in Liver Transplant Recipients Under Antiviral Prophylaxis},
journal = {Transplantation Proceedings},
year = {2025},
doi = {10.1016/j.transproceed.2025.07.006}
}
EUVIMED